By J. Jala | 10:07 AM May 11, 2021
Eric Domingo, director general of the Food and Drug Administration (FDA), confirmed Friday that his agency, Lloyd Laboratories, has issued a product registration certificate (CPR) for the manufacture and sale of ivermectin, paving the way for legal human consumption.
Nematode is a type of parasitic worm.
Inquirer reported that Domingo said the CPR, which Lloyd Laboratories applied for, deals with the use of “locally made ivermectin as an anti-nematode drug.”
“[This] was granted after submitting data in support of it [the] Quality and stability of the product,”said Domingo.
He clarified that CPR could not be used to treat or prevent Covid-19, adding that the drug’s purpose is still anti-parasitic.
However, the CPR granted to Lloyd Laboratories means anyone with a valid prescription for it can now purchase the drug.
In Bohol, Dr. Doloreich Dumaluan has appealed to the government to allow the use of anti-parasitic drug Ivermectin for
treatment and prevention purposes of coronavirus disease (Covid-19).
In his “The Doctor Is In”, Dumaluan said ivermectin has been proven to be safe and effective for years.
“Nobody died of Ivermectin,” he said.
However, the World Health Organization (WHO) said current evidence on the use of ivermectin to treat COVID-19 patients is inconclusive. Until more data is available, it ecommends that the drug be used only within clinical trials.
On Tuesday, Domingo noted that there is still not enough proof that ivermectin can treat COVID-19, since protocols for the clinical trial are still being finalized.
He said researchers from the University of the Philippines — National Institutes of Health will start recruiting potential patients for the trial by June. Results of the study may be out in four to five months.
As of this writing, there are only six hospitals granted with compassionate special permits to administer the anti-parasitic drug to coronavirus patients.